ARCHIVES

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

This article is from The Cancer Letter archive.

Vol. 35 No. 31 | August 7, 2009

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Amsacrine NDA, Renews Idarubicin

September 14, 1990

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977

Kennedy To Propose NIH Construction Authority, Legislation Using IOM Study Recommendations

January 13, 1989

NCI Advisory Group, Other Cancer Meetings

August 16, 1985

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994